Homogeneous fluorassay methods employing fluorescent background rejection and water-soluble rare earth metal chelates

• US 6,242,268 B1
• Filed: 11/02/1998
• Issued: 06/05/2001
• Est. Priority Date: 03/18/1985
• Status: Expired due to Fees

• Current Assignee: EG&G Wallac
• Original Assignee: EG&G Wallac
• Inventors: Wieder, Irwin, Hale, Ron L.
• Primary Examiner(s): Smith, Lynette R. F.
• Assistant Examiner(s): HINES, JANA A
• Application Number:
  US09/184,330
• Time in Patent Office: 946 Days
• Field of Search: 615/390, 175/41, 252/521.1, 264/21, 313/526, 378/44, 424/1.53, 424/9.6, 426/240, 436/82, 436/84, 436/172, 436/546, 536/25.32, 600/317, 600/321
• US Class Current: 436/538
• CPC Class Codes: G01N 2458/40 Rare earth chelates
• CPC Class Codes: G01N 33/533 with fluorescent label
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching

Abstract

Homogeneous assays for determining quantitatively the extent of a specific binding reaction can be carried out effectively on very dilute solutions using measurements of fluorescence if a fluorescence measurement scheme that is capable of rejecting short-lived background fluorescence is employed and if the fluorescent group being measured has the following properties: a. the group being measured must be a rare earth metal chelate complex combination; b. the chelate must be water-soluble; c. the complex combination must also be stable in extremely dilute aqueous solutions, that is, the measured chelate must have at least one ligand having a metal-to-ligand binding constant of at least about 10¹³M⁻¹ or greater and it must have a fluorescent emission that is long-lived compared to the longest decay lifetime of ambient substances and have a half life of from 0.01 to 50 msec.

Claims

1. In a homogeneous fluorescent-based detection system, the method comprising the steps of carrying out a biospecific binding reaction between a biospecific group-containing compound and a binding partner, wherein at least one of the biospecific group containing compound and the binding partner are labeled with a fluorescent tag, then exciting the solution with electromagnetic radiation and thereafter detecting the fluorescent emission from the excited solution and relating that fluorescent emission to the extent of the biospecific binding reaction, the improvement comprising:

a. admixing a water-soluble first tag-containing biospecific group-containing compound with an aqueous solution, said aqueous solution containing a biospecific counterpart of said biospecific group-containing compound group, thereby forming an aqueous solution product containing a specific binding pair, which as a result of such specific binding, contains a new tag which is different in fluorescence from the first tag, at least one of the first tag and the new tag comprising a fluorescent chelate containing a rare earth metal, the chelate being water-soluble in said aqueous solution product, and having a metal to ligand binding constant greater than about 10¹³M<sup>−

1</sup> and a decay lifetime that is longer than the longest decay lifetime of ambient substances;

b. exciting the aqueous solution product of step a. with at least one pulse of electromagnetic radiation, said pulse having a duration which is shorter than the decay lifetime of the long-lived fluorescent emission, thereby forming an excited solution product;

c. detecting the fluorescent emission from the excited aqueous solution product after the fluorescence of said ambient substances has substantially decayed; and

d. relating the fluorescence detected in c. to the extent of specific binding reaction occurring in the aqueous solution.

2. The method of claim 1, wherein each of the first tag and the new tag are rare earth metal chelate complexes, the second of which has a quenched fluorescence as a result of the specific binding reaction.

3. The method of claim 1, wherein each of the first tag and new tag are rare earth metal chelate complexes, the second of which has an enhanced fluorescence as a result of the specific binding reaction.

4. The method of claim 2, wherein the quenched fluorescence is a result of energy transfer from the first tag to a group brought into proximity with the first tag by means of the specific binding reaction.

5. The method of claim 4, wherein the proximity is a distance of from about 5 Å

to about 75Å

.

6. The method of claim 5, wherein the rare earth metal chelate comprises terbium or europium.

7. The method of claim 6, wherein the group brought into proximity with the first tag by means of the specific binding reaction is the group which undergoes the specific binding reaction.

8. The method of claim 7, wherein the group brought into proximity is anti-theophylline antibody.

9. The method of claim 8, wherein the first tag is a europium chelate of an aryl-substituted 2,6-[N,N-bis(carboxylalkyl)aminoalkyl]pyridine ligand.

10. The method of claim 7, wherein the first tag is a terbium chelate of an aryl-substituted 2,6-[N,N-bis(carboxylalkyl)aminoalkyl]pyridine ligand.

11. The method of claim 6, wherein the group brought into proximity with the first tag by means of the specific binding reaction is a group attached to the group which undergoes the specific binding reaction.

12. The method of claim 11, wherein the energy is transferred to the ligand comprising the first tag.

13. The method of claim 11, wherein the group brought into proximity is a period IV transition metal complex.

14. The method of claim 11, wherein the group brought into proximity is a rhodamine.

15. The method of claim 3, wherein the enhanced fluorescence is a result of energy transfer to the first tag from a group brought into proximity with the first tag by means of the specific binding reaction.

16. The method of claim 1, wherein the first chelate complex has a stability at least about one order of magnitude less than the stability of the new chelate complex.

17. The method of claim 16, wherein the first tag is a europium or terbium chelate of an alkylpolyaminepolycarboxylic acid, and the new tag comprises a europium or terbium chelate of an aryl-substituted 2,6-[N,N-bis(carboxylalkyl)aminoalkyl]pyridine ligand.

18. The method of claim 16, wherein the new tag comprises a europium or terbium chelate of a 2,6-[N,N-bis(carboxylalkyl)aminoalkyl]phenanthroline ligand.

19. A homogeneous method for the quantitative determination of an analyte in a sample utilizing a fluorescent-based detection system, the method comprising the steps of carrying out a biospecific binding reaction between the analyte and a binding partner or between the analyte or an analyte analogue and a binding partner, wherein at least one of the analyte analogue and the binding partner are labeled with a fluorescent tag, then exciting the solution with electromagnetic radiation and thereafter detecting the fluorescent emission from the excited solution and relating that fluorescent emission to the extent of the biospecific binding reaction, the method further comprising:

a. admixing a water-soluble first tag-containing biospecific group-containing compound with an aqueous solution, said aqueous solution containing a biospecific counterpart of said biospecific group-containing compound group, thereby forming an aqueous solution product containing a specific binding pair which as a result of such specific binding contains a new tag which is different in fluorescence from the first tag, wherein each of the first and new tags are rare earth metal chelate complexes;

b. exciting the aqueous solution product of step a. with at least one pulse of electromagnetic radiation said pulse having a duration which is shorter than the decay lifetime of the long-lived fluorescent emission, thereby forming an excited aqueous solution product;

c. detecting the fluorescent emission from the excited aqueous solution product after the fluorescence of said ambient substances has substantially decayed; and

d. relating the fluorescence detected in c. to the extent of specific binding reaction occurring in the aqueous solution.

20. A homogeneous method for the quantitative determination of a specific binding reaction in an aqueous solution which comprises:

a. admixing a water-soluble first tag-containing biospecific group-containing compound with biospecific counterpart thereby forming a specific binding pair which as a result of such specific binding contains a new tag which is different in fluorescence from the first tag, at least one of the first tag and the new tag comprising a fluorescent chelate containing a rare earth metal, the chelate being water-soluble and having a metal to ligand binding constant greater than about 10¹³M<sup>−

1</sup> and a decay lifetime that is long compared to the longest decay lifetime of ambient substances;

b. exciting the aqueous liquid product of step a. with at least one pulse of electromagnetic radiation said pulse having a duration which is short compared to the decay lifetime of the long-lived fluorescent emission;

c. detecting the fluorescent emission from the sample after the fluorescence of said ambient substances has substantially decayed;

d. and relating the fluorescence detected in c. to the extent of specific binding reaction occurring in the solution.